"Primo Capital sgr Makes First Investment in MT Ortho to Boost Innovative Healthcare Solutions"
"Primo Capital sgr, through its Primo Health fund, has made its first investment in MT Ortho, a company specializing in innovative implantable devices for neurosurgery, orthopedics, and maxillofacial reconstructive surgery. The investment involves both primary and secondary funding to support the growth of this innovative Italian industrial entity in the healthcare sector. DLA Piper provided legal counsel for the transaction, while MT Ortho was assisted by Pavia e Ansaldo. Additional support for financial, regulatory, and environmental due diligence was provided by various firms, including Grant Thornton and T8P."